"Your coffee cuts blood flow to your brain by 30%": Thomas Kirk on whether dementia drugs work

<p>Here&#39;s a fact we didn&#39;t expect: that coffee you&#39;re holding cuts blood flow to your brain by around 30%. Today&#39;s guest has built technology that can see it happening, and the bigger prize is using it to show whether the new wave of Alzheimer&#39;s drugs is working for each patient.</p><p>On today&#39;s episode, we&#39;re joined by Thomas Kirk, co-founder and CEO of Quantified Imaging. Thomas went from building ventilators with Oxford and Smith &amp; Nephew at the start of COVID, to a free vaccination-planning tool used by around half of UK GPs, to founding a company around ASL MRI: a scan that measures blood flow in the brain and costs a fraction of a PET scan. We get into why dementia drugs that only slow decline by 30% on average need a better way of tracking who&#39;s responding, why data rather than regulation is the biggest barrier to growth, the role of the University of Nottingham, and where the technology goes next, from GLP-1 obesity drugs to psychiatry.</p><p>If you enjoyed this episode, please like, subscribe and leave us a comment. </p><p>To learn more about what we&#39;re doing at SyndicateRoom, head to <a href="https://www.syndicateroom.com" target="_blank" rel="noopener noreferer">syndicateroom.com</a> or follow <a href="https://www.linkedin.com/in/tombritton/" target="_blank" rel="noopener noreferer">Tom Britton on LinkedIn</a>.</p><p></p>